Abstract:Recent reviews support the observation that essential thrombocytosis in young patients is not always without risk. Thrombotic complications include acute myocardial infarction and stroke [l, 21 in addition to recurrent abortions and stillbirths presumably related to placental infarction [3-51. At the time of our previous report, our second patient had been lost to follow-up. She recently was seen in another centre at which time she was pregnant for the eighth time. She reported a total of seven spontaneous a… Show more
“…Those who prescribed regular aspirin discontinued the medication 2 weeks before delivery [6, 10, 12, 13, 14, 17, 23, 26, 27, 29, 31]. In some of these cases, LMWH was then commenced [10, 17, 23, 29, 31, 33].…”
It is advisable to treat essential thrombocythemia (ET) during pregnancy, because elevated platelet counts can lead to maternal and fetal complications. In order to establish which therapy is more favorable, we undertook a review of the literature. In addition to our own case, we found 27 reports which described 75 cases with 143 pregnancies. We discussed the complications of ET during pregnancy and postpartum, fetal outcome and the therapeutic strategies. Considering the clear risk of complications during pregnancy – especially the occurrence of spontaneous abortion in the first trimester – and the risk of intrauterine fetal death, we believe all patients should at least be treated with aspirin unless there is a contraindication. Platelet reduction with interferon-α (IFN-α) might be able to further reduce the complications of ET during pregnancy and to improve fetal outcome (data from 14 patients). After treatment with IFN-α, sufficient numbers of umbilical cord blood stem cells can be collected.
“…Those who prescribed regular aspirin discontinued the medication 2 weeks before delivery [6, 10, 12, 13, 14, 17, 23, 26, 27, 29, 31]. In some of these cases, LMWH was then commenced [10, 17, 23, 29, 31, 33].…”
It is advisable to treat essential thrombocythemia (ET) during pregnancy, because elevated platelet counts can lead to maternal and fetal complications. In order to establish which therapy is more favorable, we undertook a review of the literature. In addition to our own case, we found 27 reports which described 75 cases with 143 pregnancies. We discussed the complications of ET during pregnancy and postpartum, fetal outcome and the therapeutic strategies. Considering the clear risk of complications during pregnancy – especially the occurrence of spontaneous abortion in the first trimester – and the risk of intrauterine fetal death, we believe all patients should at least be treated with aspirin unless there is a contraindication. Platelet reduction with interferon-α (IFN-α) might be able to further reduce the complications of ET during pregnancy and to improve fetal outcome (data from 14 patients). After treatment with IFN-α, sufficient numbers of umbilical cord blood stem cells can be collected.
“…In accordance with these observations, multiple focal infarctions were also detected in the pathological examination of our placenta. This has been primarily described in association with late fetal loss [10] , preterm delivery [10,11] and in- trauterine growth restriction [12][13][14][15] . Niittyvuopio et al [16] and other previous studies have shown that pregnancy-related complications in ET are difficult to predict [16][17][18] .…”
We report a case of prenatally diagnosed intracranial hemorrhage and hydrops in the fetus of a mother with a past history of surgical and medical treatment for gastric lymphoma and having high platelet counts thereafter. To the best of our knowledge, such a complication of maternal thrombocythemia has not been described in the literature. In our opinion, the possible pathophysiology of the disease is based on placental insufficiency due to infarctions and related fetal platelet dysfunction, leading to intracranial hemorrhage with subsequent hydrops fetalis. The trigger in this event appears to be trauma to the maternal abdomen. Certain measures for high-risk mothers such as avoidance of trauma to the abdomen and platelet-lowering medications like interferon-α may be useful for preventing such fetal complications.
“…There are reports in patients with a history of abortions that had a successful pregnancy after single treatment with ASA [5,6,8,9,16,[19][20][21][22][23][24][25]. ASA was also initiated in some cases, if not at the beginning of pregnancy, when a pregnancy complication was present like hypertension disorders, abrutio placenta or IUGR and premature delivery [5,8,[25][26][27].…”
Section: Low Dose Aspirin and Other Antiplatelet Agentsmentioning
Treatment of patients with essential thrombocytosis during pregnancy is challenging and young women are reported to be at increased risk of first trimester abortions and other pregnancy complications. In literature, there are case reports and small case series where the treatment approach differs and the results are conflicting. The addition of low dose aspirin seems to be beneficial in most cases improving pregnancy outcome whereas interferon-a is the cytoreductive drug of choice when platelet control is needed during pregnancy. Anticoagulation with low-molecular weight heparin is not generally recommended and should be considered during the last few weeks of pregnancy and postpartum.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.